Currently Browsing

Our Products

Fenofibric Acid Delayed-Release Capsules 135 mg – 90/Bottle

Overview

Reference Brand:
Trilipix®
Therapeutic Class:
Cardiovascular

Specifications

GCN:
16105
Strength:
135 mg
Size:
90
NDC #:
59651021790
TE Code:
AB

Order Information

Case Qty (min order qty):
24
Case Weight (lbs):
4.766

Attributes

Physical Form:
Capsules
Shape:
Capsules
Color:
Blue/Yellow
Imprint:
"CFB" / "135"
Prescribing Info
Product News

July 22, 2026 | Aurobindo Receives FDA Approval for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5% ... Read more

Product News

July 21, 2026 | Aurobindo Receives FDA Approval for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 150 mg and 300 mg ... Read more

Product News

July 15, 2026 | Aurobindo Receives FDA Approval for Etodolac Tablets USP, 400 mg and 500 mg ... Read more